IPO registrations (S-1, F-1) · Registrants
RxSight, Inc.
- SEC CIK
- 1111485 · filings on EDGAR ↗
- Former names
- CALHOUN VISION INC (2002–2014)
- Registration
- Form S-1, first filed 2021-07-09, last 2021-07-28; 1 initial registration, 2 amendments
- Outcome
- Final prospectus filed 2021-07-30; declared effective 2021-07-29
- Industry (SIC)
- Ophthalmic Goods 3851
- Incorporated in
- DE
- Business address
- 100 COLUMBIA STREET, SUITE 120, Aliso Viejo, CA 92656
- EIN
- 94-3268801
- Ticker
- RXST (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- RxSight, Inc. on the corporate pages
Offering terms
- Proposed price range
- $16.00–$18.00 per share (S-1/A filed 2021-07-28)
- Final price
- $12.40 per share, below the range (424B4 filed 2021-07-30, an initial public offering)
- Shares sold
- 7,350,000
- Gross proceeds
- $91,140,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol RXST
- Lead underwriters
- J.P. Morgan (2,756,250 shares); BofA Securities (2,572,500 shares)
- Syndicate
- Leerink Partners (918,750); Wells Fargo (735,000); BTIG (367,500)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: RXSIGHT, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: RXSIGHT, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: RxSight, Inc. Fuzzy (name and state)
- Business registration: RxSight, Inc. Fuzzy (name and state)
- Business registration: RXSIGHT, INC. Fuzzy (name and state)
- Business registration: RXSIGHT, INC. Fuzzy (name and state)
- Business registration: RXSIGHT, INC. Fuzzy (name and state)
- Business registration: RXSIGHT, INC. Fuzzy (name and state)
- Business registration: RXSIGHT, INC. Fuzzy (name and state)
- Business registration: RXSIGHT, INC. Fuzzy (name and state)
- Business registration: RXSIGHT, INC. Fuzzy (name and state)
- Business registration: RXSIGHT, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: RXSIGHT, INC. EXACT (EIN (EXACT))
- Form D issuer: RxSight, Inc. EXACT (CIK (EXACT))
- SEC filer: RxSight, Inc. EXACT (CIK (EXACT))
Filings 6
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-07-09 | S-1 | S-1 (registration) | RxSight, Inc. | 0001193125-21-211793 ↗ |
| 2021-07-26 | S-1/A | S-1/A (amendment) | RxSight, Inc. | 0001193125-21-223690 ↗ |
| 2021-07-28 | S-1/A | S-1/A (amendment) | RxSight, Inc. | 0001193125-21-226143 ↗ |
| 2021-07-29 | EFFECT | EFFECT (declared effective) | RxSight, Inc. | 9999999995-21-002978 ↗ |
| 2021-07-30 | 424B4 | 424B4 (final prospectus) | RxSight, Inc. | 0001193125-21-231508 ↗ |
| 2022-08-12 | EFFECT | EFFECT (declared effective) | RxSight, Inc. | 9999999995-22-002372 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-28 | S-1/A | registration statement | $16.00–$18.00 | 7,350,000 | - | Nasdaq RXST | 5 | primary document; range, shares headline, cover names 5 | document ↗ | |
| 2021-07-30 | 424B4 | final prospectus | $12.40 | 7,350,000 | $91,140,000 | Nasdaq RXST | 5 | primary document; price line, shares headline, proceeds computed, underwriting table 5, cover names 5 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Corley Jesse Anderson | Director | 16 | 2021–2026 | ||
| Cox Christopher | Director | 1 | 2021 | ||
| Goldshleger Ilya | Officer | Chief Operating Officer; See remarks | 38 | 2021–2026 | |
| Kurtz Ronald M MD | Director,Officer; Officer | Chief Medical Officer; President & CEO; See Remarks | 16 | 2021–2026 | |
| LINK WILLIAM J PHD | Director; Director,TenPercentOwner | 18 | 2021–2026 | ||
| Robertson Bruce C | Director | 2 | 2021 | ||
| RxSight I, LLC | TenPercentOwner | 2 | 2021 | ||
| Schwartz Daniel Mark | Director | 2 | 2021 | ||
| Tammenoms Bakker Juliet | Director | 19 | 2021–2026 | ||
| Thunen Shelley B | Officer | Chief Financial Officer; See remarks | 17 | 2021–2025 | |
| Weinberg Eric | Officer | Chief Commercial Officer; See remarks | 19 | 2021–2026 | |
| Wolfen Richard M. | Director | 2 | 2021 | ||
| Andrews Julie | Director | 8 | 2021–2026 | ||
| PALMISANO ROBERT J | Director | 7 | 2021–2026 | ||
| Warner Robert Keith | Director | 9 | 2021–2026 | ||
| Kolchinsky Peter | TenPercentOwner | 1 | 2021 | ||
| RA Capital Healthcare Fund LP | TenPercentOwner | 1 | 2021 | ||
| RA CAPITAL MANAGEMENT, L.P. | TenPercentOwner | 1 | 2021 | ||
| Shah Rajeev M. | TenPercentOwner | 1 | 2021 | ||
| Fountain Tamara | Director | 7 | 2022–2026 | ||
| Maniar Shweta | Director | 12 | 2022–2026 | ||
| COHEN RAYMOND W | Director | 3 | 2025–2026 | ||
| Gaines Scott | Officer | Chief Customer Officer | 2 | 2026 | |
| Wilterding Mark | Officer | Chief Financial Officer | 5 | 2026 | |
| Mottiwala Aziz | Director,Officer | President and CEO | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2017-03-08 | RxSight, Inc. | Other Health Care | $77,499,999 | $49,975,202 | 62 | 2 |
| 2014-03-20 | CALHOUN VISION INC | Other Technology | $47,000,000 | $12,715,000 | 45 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.